COMP <GO>
DORM vs PG // RETURN ON INVESTED CAPITAL (ROIC)
Dorman Products Inc. (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: DORM 5
— PG 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: PG
LAST: $133.67 (+3.03%) • MKT CAP: $3.94B
roic
12.90%
LAST: $160.59 (+1.47%) • MKT CAP: $372.21B
roic
25.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DORM VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DORM | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.10% | 51.20% | -9.10 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 12.90% | 25.40% | -12.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.9x | 16.2x | -3.30 | DORM | /valuation <GO> |
| Free Cash Flow Yield | 1.92% | 3.77% | -1.85 | PG | /fcf-yield <GO> |
| Operating Margin | 14.10% | 24.30% | -10.20 | PG | /operating-margins <GO> |
| Net Profit Margin | 9.60% | 19.00% | -9.40 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 6.00% | 0.30% | +5.70 | DORM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.59 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | DORM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.5 | 60.3 | +3.20 | DORM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.9x | 21.7x | -3.80 | DORM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.94B | $372.21B | -$368.27B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DORM REV | PG REV | DORM GROSS % | PG GROSS % | DORM FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.13B | $84.28B | 42.1% | 51.2% | $75.7M | $14.04B |
| FY 2024 | $2.01B | $84.04B | 40.1% | 51.4% | $191.6M | $16.52B |
| FY 2023 | $1.93B | $82.01B | — | — | $208.8M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DORM // BETA —
PG // BETA 0.87